Trachoma, a leading cause of preventable blindness in the world, may be caused by Chlamydiaceae species other than Chlamydia trachomatis, according to a report in the January PLoS Medicine. Reuters Health Information
In this Special Report, expert hematologists review the epidemiology of thrombocytopenia in patients with leukemia and review current and investigational therapies that may help overcome this problem. Medscape Hematology-Oncology
This Expert Column details current management strategies for thrombocytopenia -- a common and significant problem in patients with leukemia -- as well as potential new treatment approaches. Medscape Hematology-Oncology
Dr. Daniel J. Weisdorf discusses the role of platelet transfusion and the criteria that newer treatments must satisfy to be of value in the treatment of thrombocytopenia in leukemia. Medscape Hematology-Oncology
In this Expert Interview from ASH 2007, Dr. Jorge Cortes discusses new and follow-up data from clinical trials of drug therapies for CML. Medscape Hematology-Oncology
New research shows that high-dose methotrexate is the most effective drug for primary central nervous system lymphoma, with up to 20% of patients achieving a long-term remission with methotrexate alone. Medscape Medical News
A new pooled analysis of data collected in 18 previous studies shows no significant relation between serum levels of sex hormones and risk for prostate cancer, thus debunking the androgen-driven hypothesis. Medscape Medical News
